Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Dexmedetomidine, Remifentanil and Metoral on Intraoperative Bleeding and Satisfaction in Rhinoplasty
IRCT20180903040936N2Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine, remifentanil and metformin (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Intraoperative bleeding and Surgical satisfaction. Started Aug 2019; status: completed.
02
Drugs
dexmedetomidineremifentanilmetformin
Beyond the preview
Go deeper on IRCT20180903040936N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180903040936N2.